tirzepatide approval canada FDA Grants a New Indication for Obesity Management Mounjaro in Canada: Where To
Description
Forty female Wistar rats were allocated to four experimental groups: Control, DXN (5 mg/kg body weight (BW)), TIR (1.35 mg/kg BW), and DXN + TIR (5 mg DXN/kg BW followed by 1.35 mg TIR/kg BW)

Alcohol should also be avoided if you cannot keep fluids down, feel faint, or are having significant digestive symptoms
Glycemic control generally deteriorates progressively after tirzepatide cessation, with HbA1c levels moving toward pre-treatment values without alternative therapy

Fast, up-to-date, have everything you need
For individuals considering breastfeeding while taking tirzepatide, schedule a preconception or early postpartum consultation with both your endocrinologist and obstetrician

This makes the prospect of using medications like tirzepatide, which can induce significant weight loss, particularly appealing for individuals managing both obesity and GERD
